Suppr超能文献

人白细胞介素-20受体重组细胞外结构域及其与白细胞介素-19和白细胞介素-20复合物的特性

Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20.

作者信息

Pletnev Sergei, Magracheva Eugenia, Kozlov Serguei, Tobin Gregory, Kotenko Sergei V, Wlodawer Alexander, Zdanov Alexander

机构信息

Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Maryland 21702-1201, USA.

出版信息

Biochemistry. 2003 Nov 4;42(43):12617-24. doi: 10.1021/bi0354583.

Abstract

The soluble extracellular domains of human interleukin-20 (IL-20) receptors I and II (sIL-20R1 and sIL20R2), along with their ligands IL-19 and IL-20, were expressed in Drosophila S2 cells and purified to homogeneity. Formation of the receptor/receptor and ligand/receptor complexes was studied by size exclusion chromatography. Both ligands and soluble receptors were found to be monomeric in solution; homo- or heterodimers are not formed even at elevated concentrations. Under native conditions, both IL-19 and IL-20 form stable ternary 1:1:1 complexes with the sIL-20R1 and sIL20R2 receptors, as well as high-affinity binary complexes with sIL-20R2. Unexpectedly, sIL-20R1 does not bind on its own to either IL-19 or IL-20. Thus, one of the possible consecutive mechanisms of formation of the signaling ternary complex may involve two steps: first, the ligand binds to receptor II, creating a high-affinity binding site for the receptor I, and only then does receptor I complete the complex.

摘要

人白细胞介素20(IL-20)受体I和II(sIL-20R1和sIL20R2)的可溶性细胞外结构域,连同其配体IL-19和IL-20,在果蝇S2细胞中表达并纯化至同质。通过尺寸排阻色谱法研究受体/受体和配体/受体复合物的形成。发现配体和可溶性受体在溶液中均为单体;即使在高浓度下也不会形成同二聚体或异二聚体。在天然条件下,IL-19和IL-20均与sIL-20R1和sIL20R2受体形成稳定的三元1:1:1复合物,以及与sIL-20R2形成高亲和力的二元复合物。出乎意料的是,sIL-20R1自身不与IL-19或IL-20结合。因此,信号三元复合物形成的可能连续机制之一可能涉及两个步骤:首先,配体与受体II结合,为受体I创造一个高亲和力结合位点,然后受体I才完成复合物的形成。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验